Boston Scientific (UK) Today
| 0HOY Stock | 89.17 0.04 0.04% |
Performance7 of 100
| Odds Of DistressLess than 9
|
Boston Scientific is selling for under 89.17 as of the 21st of December 2024; that is 0.04% up since the beginning of the trading day. The stock's lowest day price was 87.25. Boston Scientific has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 21st of November 2024 and ending today, the 21st of December 2024. Click here to learn more.
Business Domain Commercial & Professional Services | Classification Industrials |
Boston Scientific is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 1.38 B outstanding shares. More on Boston Scientific Corp
Moving together with Boston Stock
Moving against Boston Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Boston Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boston Scientific's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boston Scientific or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Chairman | Michael Mahoney | ||||
| Business Concentration | Environmental & Facilities Services, Commercial & Professional Services, Industrials, Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors) | ||||
Boston Scientific's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Boston Scientific's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Boston Scientific can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Boston Scientific's financial leverage. It provides some insight into what part of Boston Scientific's total assets is financed by creditors.
| |||||
Boston Scientific Corp (0HOY) is traded on London Exchange in UK and employs 48,000 people. Boston Scientific is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 104.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boston Scientific's market, we take the total number of its shares issued and multiply it by Boston Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boston Scientific Corp operates under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 1.38 B outstanding shares.
Boston Scientific generates positive cash flow from operations, but has no cash available
Check Boston Scientific Probability Of Bankruptcy
Ownership AllocationBoston Scientific holds a total of 1.38 Billion outstanding shares. The majority of Boston Scientific Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Boston Scientific Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Boston Scientific. Please pay attention to any change in the institutional holdings of Boston Scientific Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Boston Ownership Details
Boston Scientific Corp Risk Profiles
Although Boston Scientific's alpha and beta are two of the key measurements used to evaluate Boston Scientific's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.7543 | |||
| Semi Deviation | 0.7764 | |||
| Standard Deviation | 1.09 | |||
| Variance | 1.19 |
Boston Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boston Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Boston Scientific Corporate Management
Elected by the shareholders, the Boston Scientific's board of directors comprises two types of representatives: Boston Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boston. The board's role is to monitor Boston Scientific's management team and ensure that shareholders' interests are well served. Boston Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boston Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Catherine Jennings | VP Interventions | Profile | |
| Emily Woodworth | Global VP | Profile | |
| Jodi Eddy | Senior Officer | Profile | |
| John Sorenson | Executive Operations | Profile | |
| Arthur Butcher | Executive Pacific | Profile |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.